GW&K Investment Management LLC Increases Stock Position in Azenta, Inc. $AZTA

GW&K Investment Management LLC grew its holdings in shares of Azenta, Inc. (NASDAQ:AZTA) by 37.1% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 1,550,101 shares of the company’s stock after buying an additional 419,630 shares during the period. GW&K Investment Management LLC’s holdings in Azenta were worth $51,556,000 as of its most recent SEC filing.

Other institutional investors also recently modified their holdings of the company. Vanguard Group Inc. grew its holdings in Azenta by 2.2% in the fourth quarter. Vanguard Group Inc. now owns 4,538,946 shares of the company’s stock worth $150,965,000 after purchasing an additional 99,588 shares during the period. Millennium Management LLC boosted its position in shares of Azenta by 41.6% in the 3rd quarter. Millennium Management LLC now owns 1,698,562 shares of the company’s stock worth $48,783,000 after purchasing an additional 499,216 shares in the last quarter. Allspring Global Investments Holdings LLC boosted its position in shares of Azenta by 7.8% in the 4th quarter. Allspring Global Investments Holdings LLC now owns 1,388,047 shares of the company’s stock worth $46,347,000 after purchasing an additional 99,897 shares in the last quarter. Congress Asset Management Co. purchased a new stake in shares of Azenta in the 4th quarter worth approximately $42,755,000. Finally, Massachusetts Financial Services Co. MA purchased a new stake in shares of Azenta in the 4th quarter worth approximately $36,803,000. 99.08% of the stock is currently owned by institutional investors.

Azenta Stock Up 0.0%

Shares of AZTA opened at $22.72 on Wednesday. Azenta, Inc. has a twelve month low of $15.93 and a twelve month high of $41.73. The company has a market capitalization of $1.05 billion, a P/E ratio of -5.74 and a beta of 1.39. The firm has a 50 day moving average of $21.91 and a 200 day moving average of $28.38.

Azenta (NASDAQ:AZTA) last released its quarterly earnings data on Wednesday, May 6th. The company reported ($0.04) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.12 by ($0.16). Azenta had a negative net margin of 30.49% and a positive return on equity of 1.23%. The business had revenue of $144.80 million during the quarter, compared to the consensus estimate of $148.47 million. During the same period last year, the company posted $0.01 earnings per share. The business’s revenue was up 1.4% compared to the same quarter last year.

Analyst Ratings Changes

AZTA has been the subject of a number of recent research reports. Needham & Company LLC lowered their price objective on Azenta from $44.00 to $33.00 and set a “buy” rating for the company in a research note on Wednesday, May 6th. Weiss Ratings upgraded Azenta from a “sell (e+)” rating to a “sell (d-)” rating in a report on Monday, May 18th. Four analysts have rated the stock with a Buy rating, three have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Hold” and a consensus target price of $39.50.

About Azenta

Azenta, Inc (NASDAQ: AZTA) is a life sciences technology company specializing in sample management, cryogenic storage and genomic services for research and clinical applications. Formerly the Life Sciences division of Brooks Automation, Azenta provides integrated solutions that enable customers to store, track and analyze biological samples with high levels of automation, data integrity and efficiency. Its offerings span automated storage systems, biorepository management software and end‐to‐end sample tracking workflows.

In addition to hardware and informatics platforms for sample storage, Azenta’s Genomics business delivers next‐generation sequencing (NGS), DNA synthesis, and molecular biology services.